Johan Askling (J Askling)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 55

Top Venues

RMD open

Annals of the rheumatic diseases

ACR open rheumatology

Scandinavian journal of rheumatology

Karolinska Institutet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet

Sweden

Professor :: Department of Medicine Solna

Publications

Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology 5 (5) (2023)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Sofia Exarchou, Daniela Di Giuseppe, Eva Klingberg, Valgerdur Sigurdardottir, Sara Wedrén, Ulf Lindström, Carl Turesson, Lennart T H Jacobsson, Johan Askling, Johan Karlsson Wallman
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study. Annals of the rheumatic diseases (2023)
Karin Bengtsson, Johan Askling, Mattias Lorentzon, Björn Rosengren, Anna Deminger, Eva Klingberg, Lennart Jacobsson, Helena Forsblad-d'Elia
Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden. RMD open 9 (1) (2023)
Eleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, Lars Klareskog, Lars Alfredsson, Linda Mathsson-Alm, Monika Hansson, Martin Cornillet Jeannin, Guy Serre, Rickard Holmdahl, Karl Skriner, Per-Johan Jakobsson, Helga Westerlind, Johan Askling, Johan Rönnelid
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Annals of the rheumatic diseases (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Johan Askling
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis. RMD open 9 (4) (2023)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Hilde Berner Hammer, Sigve Lans Pedersen, Maria K Jonsson, Linda Mathsson-Alm, Isabel Gehring, Joe Sexton, Espen A Haavardsholm, Johan Askling
Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods. Scandinavian journal of clinical and laboratory investigation (2023)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Viking Huss, Hannah Bower, Karin Hellgren, Thomas Frisell, Johan Askling, null null, null null
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study. Annals of the rheumatic diseases (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Karin Bengtsson, Johan Askling, Mattias Lorentzon, Björn Rosengren, Anna Deminger, Eva Klingberg, Lennart Jacobsson, Helena Forsblad-d'Elia
Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden. RMD open 9 (1) (2023)
Thomas Frisell, Hannah Bower, Matilda Morin, Eva Baecklund, Daniela Di Giuseppe, Bénédicte Delcoigne, Nils Feltelius, Helena Forsblad-d'Elia, Elisabet Lindqvist, Ulf Lindström, Johan Askling, null null
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme. Annals of the rheumatic diseases (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology 5 (5) (2023)
Teresa A Simon, Lixian Dong, Samy Suissa, Kaleb Michaud, Sofia Pedro, Marc Hochberg, Maarten Boers, Johan Askling, Thomas Frisell, Anja Strangfeld, Yvette Meißner, Vadim Khaychuk, Alyssa Dominique, Michael A Maldonado
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies. Annals of the rheumatic diseases (2023)
Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
Joakim Lindqvist, Johan Askling, Jon Lampa
Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis. RMD open 9 (4) (2023)
Bénédicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open 9 (1) (2023)
Bénédicte Delcoigne, AnnaCarin Horne, Johan Reutfors, Johan Askling
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses. ACR open rheumatology 5 (5) (2023)
Bente Glintborg, Daniela Di Giuseppe, Johan Karlsson Wallman, Dan C Nordström, Bjorn Gudbjornsson, Merete Lund Hetland, Johan Askling, Gerdur Grondal, Tuulikki Sokka, Sella Aarrestad Provan, Brigitte Michelsen, Eirik Klami Kristianslund, Lene Dreyer, Thorvardur Jon Love, Ulf Lindström
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries. Annals of the rheumatic diseases (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study. RMD open 9 (4) (2023)
David Bergman, Bjorn Roelstraete, Jiangwei Sun, Fahim Ebrahimi, Johan Askling, Jonas F Ludvigsson
Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population-based matched cohort study. Alimentary pharmacology & therapeutics (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Helga Westerlind, Bente Glintborg, Hilde Berner Hammer, Saedis Saevarsdottir, Niels Steen Krogh, Merete Lund Hetland, Ellen-Margrethe Hauge, Isabel Martinez Tejada, Joseph Sexton, Johan Askling
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts. RMD open 9 (3) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Karin Bengtsson, Johan Askling, Mattias Lorentzon, Björn Rosengren, Anna Deminger, Eva Klingberg, Lennart Jacobsson, Helena Forsblad-d'Elia
Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden. RMD open 9 (1) (2023)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad-d'Elia, Johan Askling
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 9 (4) (2023)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study. RMD open 8 (2) (2022)
Rene Lindholm Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Bjorn Gudbjornsson, Thorvardur Jon Love, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD open 8 (2) (2022)
Bénédicte Delcoigne, Lotta Ljung, Sella A Provan, Bente Glintborg, Merete Lund Hetland, Kathrine Lederballe Grøn, Ritva Peltomaa, Heikki Relas, Carl Turesson, Bjorn Gudbjornsson, Brigitte Michelsen, Johan Askling
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries. Annals of the rheumatic diseases 81 (6) (2022)
Rene Lindholm Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Bjorn Gudbjornsson, Thorvardur Jon Love, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD open 8 (2) (2022)
Vanessa L Kronzer, Helga Westerlind, Lars Alfredsson, Cynthia S Crowson, Lars Klareskog, Marie Holmqvist, Johan Askling
Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control study. RMD open 8 (1) (2022)
Katerina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, Anca Catrina, Johan Askling
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking. RMD open 8 (2) (2022)
Saedis Saevarsdottir, Lilja Stefansdottir, Patrick Sulem, Gudmar Thorleifsson, Egil Ferkingstad, Gudrun Rutsdottir, Bente Glintborg, Helga Westerlind, Gerdur Grondal, Isabella C Loft, Signe Bek Sorensen, Benedicte A Lie, Mikael Brink, Lisbeth Ärlestig, Asgeir Orn Arnthorsson, Eva Baecklund, Karina Banasik, Steffen Bank, Lena I Bjorkman, Torkell J Ellingsen, Christian Erikstrup, Oleksandr Frei, Inger Gjertsson, Daniel F Gudbjartsson, Sigurjon A Gudjonsson, Gisli H Halldorsson, Oliver Hendricks, Jan Hillert, Estrid Hogdall, Søren Jacobsen, Dorte Vendelbo Jensen, Helgi Jonsson, Alf Kastbom, Ingrid Kockum, Salome Kristensen, Helga Kristjansdottir, Margit H Larsen, Asta Linauskas, Ellen-Margrethe Hauge, Anne G Loft, Bjorn R Ludviksson, Sigrun H Lund, Thorsteinn Markusson, Gisli Masson, Pall Melsted, Kristjan H S Moore, Heidi Lausten Munk, Kaspar R Nielsen, Gudmundur L Norddahl, Asmundur Oddsson, Thorunn A Olafsdottir, Pall I Olason, Tomas Olsson, Sisse Rye Ostrowski, Kim Hørslev-Petersen, Solvi Rognvaldsson, Helga Sanner, Gilad N Silberberg, Hreinn Stefansson, Erik Sørensen, Inge J Sørensen, Carl Turesson, Thomas Bergman, Lars Alfredsson, Tore K Kvien, Søren Brunak, Kristján Steinsson, Vibeke Andersen, Ole A Andreassen, Solbritt Rantapää Dahlqvist, Merete Lund Hetland, Lars Klareskog, Johan Askling, Leonid Padyukov, Ole Bv Pedersen, Unnur Thorsteinsdottir, Ingileif Jonsdottir, Kari Stefansson, null null, null null, null null
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Annals of the rheumatic diseases 81 (8) (2022)
Viktor Molander, Hannah Bower, Johan Askling
Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis. Scandinavian journal of rheumatology (2022)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study. RMD open 8 (2) (2022)
Johan Karlsson Wallman, G-M Alenius, Eva Klingberg, Valgerdur Sigurdardottir, S Wedrén, Sofia Exarchou, Ulf Lindström, Daniela di Giuseppe, Johan Askling, Lennart T H Jacobsson
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register. Scandinavian journal of rheumatology (2022)
Liselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, Johan Askling, Saedis Saevarsdottir
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study. RMD open 8 (2) (2022)
Viktor Molander, Hannah Bower, Thomas Frisell, Bénédicte Delcoigne, Daniela Di Giuseppe, Johan Askling, null null
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Rene Lindholm Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Bjorn Gudbjornsson, Thorvardur Jon Love, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD open 8 (2) (2022)
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Johan Askling
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19? Annals of the rheumatic diseases (2021)
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling, null null
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study. Annals of the rheumatic diseases (2021)
Ulf Lindström, Karin Bengtsson, Tor Olofsson, Daniela Di Giuseppe, Bente Glintborg, Helena Forsblad-d'Elia, Lennart T H Jacobsson, Johan Askling
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Annals of the rheumatic diseases 80 (11) (2021)
Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne, Bente Glintborg, Burkhard Möller, Adrian Ciurea, Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Kari Eklund, Heikki Relas, Bjorn Gudbjornsson, Thorvardur Jon Love, Gareth T Jones, Catalin Codreanu, Ruxandra Ionescu, Lucie Nekvindova, Jakub Závada, Nuh Atas, Servet Yolbas, Karen Minde Fagerli, Brigitte Michelsen, Žiga Rotar, Matija Tomšič, Florenzo Iannone, Maria Jose Santos, Pedro Avila-Ribeiro, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Lennart Th Jacobsson, Johan Askling, Michael J Nissen
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration. Annals of the rheumatic diseases 80 (11) (2021)
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Gerd-Marfie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling, null null
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision. RMD open 7 (3) (2021)
Helga Westerlind, Bénédicte Delcoigne, Johan Askling
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study. RMD open 6 (1) (2021)
Viktor Molander, Johan Askling
Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden'' by Zervou et al. Annals of the rheumatic diseases (2021)
Bonnie Bengtsson, Johan Askling, Jonas F Ludvigsson, Hannes Hagström
Validity of administrative codes associated with cirrhosis in Sweden. Scandinavian journal of gastroenterology 55 (10) (2020)
Helga Westerlind, Johan Rönnelid, Monika Hansson, Lars Alfredsson, Linda Mathsson-Alm, Guy Serre, Martin Cornillet, Rikard Holmdahl, Per-Johan Jakobsson, Karl Skriner, Lars Klareskog, Saedis Saevarsdottir, Johan Askling
Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 72 (10) (2020)
Marios Rossides, Susanna Kullberg, Johan Askling, Anders Eklund, Johan Grunewald, Daniela di Giuseppe, Elizabeth V Arkema
Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study. European journal of epidemiology 35 (11) (2020)

Johan Askling.css-eqlu8i{font-size:small;padding-left:4px;} (J Askling)

Publication Activity (10 Years)

Top Topics

Top Venues

Johan Askling (J Askling)